Mesothelin expression in esophageal adenocarcinoma and squamous cell carcinoma and its possible impact on future treatment strategies

BACKGROUND: Mesothelin is expressed at very low levels by normal mesothelial cells but is overexpressed in several human cancers. This makes mesothelin a promising target for immunotherapy. Limited data exist about mesothelin expression in esophageal carcinoma. In a current clinical trial, the highl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Adv Med Oncol
Autors principals: Moentenich, Valeska, Comut, Erdem, Gebauer, Florian, Tuchscherer, Armin, Bruns, Christiane, Schroeder, Wolfgang, Buettner, Reinhard, Alakus, Hakan, Loeser, Heike, Zander, Thomas, Quaas, Alexander
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7249595/
https://ncbi.nlm.nih.gov/pubmed/32547645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920917571
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars